RU2015143965A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2015143965A3 RU2015143965A3 RU2015143965A RU2015143965A RU2015143965A3 RU 2015143965 A3 RU2015143965 A3 RU 2015143965A3 RU 2015143965 A RU2015143965 A RU 2015143965A RU 2015143965 A RU2015143965 A RU 2015143965A RU 2015143965 A3 RU2015143965 A3 RU 2015143965A3
- Authority
- RU
- Russia
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361792440P | 2013-03-15 | 2013-03-15 | |
| US61/792,440 | 2013-03-15 | ||
| PCT/US2014/029421 WO2014144842A2 (en) | 2013-03-15 | 2014-03-14 | Pharmaceutical compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019116003A Division RU2844779C2 (ru) | 2013-03-15 | 2014-03-14 | Фармацевтические композиции |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2015143965A RU2015143965A (ru) | 2017-04-24 |
| RU2015143965A3 true RU2015143965A3 (enExample) | 2018-02-05 |
| RU2690377C2 RU2690377C2 (ru) | 2019-06-03 |
Family
ID=50732290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015143965A RU2690377C2 (ru) | 2013-03-15 | 2014-03-14 | Фармацевтические композиции |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US11129869B2 (enExample) |
| EP (2) | EP3778623A1 (enExample) |
| JP (4) | JP6538025B2 (enExample) |
| KR (1) | KR102378943B1 (enExample) |
| CN (3) | CN105518021A (enExample) |
| AU (5) | AU2014228460B2 (enExample) |
| BR (1) | BR112015023409B1 (enExample) |
| CA (2) | CA3209602A1 (enExample) |
| DK (1) | DK2970389T3 (enExample) |
| ES (1) | ES2825076T3 (enExample) |
| FR (1) | FR21C1059I2 (enExample) |
| IL (2) | IL288961B1 (enExample) |
| NL (1) | NL301149I2 (enExample) |
| NO (1) | NO2021051I1 (enExample) |
| PL (1) | PL2970389T3 (enExample) |
| PT (1) | PT2970389T (enExample) |
| RU (1) | RU2690377C2 (enExample) |
| WO (1) | WO2014144842A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100734T1 (it) | 2011-12-29 | 2022-03-21 | Rhythm Pharmaceuticals Inc | Metodo di trattamento di disturbi associati al recettore di melanocortina 4 in portatori eterozigoti |
| JP6622690B2 (ja) | 2013-03-15 | 2019-12-18 | リズム・ファーマシューティカルズ・インコーポレイテッド | ペプチド組成物 |
| JP6538025B2 (ja) * | 2013-03-15 | 2019-07-03 | リズム・ファーマシューティカルズ・インコーポレイテッド | 医薬組成物 |
| US10835549B2 (en) | 2013-04-11 | 2020-11-17 | Vanderbilt University | Polyplexes |
| WO2016168388A2 (en) | 2015-04-14 | 2016-10-20 | Palatin Technologies, Inc. | Therapies for obesity, diabetes and related indications |
| MX2018003983A (es) * | 2015-09-30 | 2018-11-09 | Rhythm Pharmaceuticals Inc | Metodo de tratamiento de trastornos asociados a la via del receptor de melanocortina-4. |
| JP6701572B2 (ja) * | 2016-07-05 | 2020-05-27 | 株式会社リコー | インク、収容容器、画像形成方法及び画像形成装置 |
| JP7217700B2 (ja) | 2016-09-13 | 2023-02-03 | アラーガン、インコーポレイテッド | 安定化非タンパク質クロストリジウム毒素組成物 |
| US20200223889A1 (en) | 2017-03-15 | 2020-07-16 | Novo Nordisk A/S | Bicyclic Compounds Capable of Binding to Melanocortin 4 Receptor |
| BR112020002804A2 (pt) | 2017-08-24 | 2020-07-28 | Novo Nordisk A/S | composição farmacêutica líquida, e, kit |
| WO2019099735A1 (en) * | 2017-11-15 | 2019-05-23 | Rhythm Pharmaceuticals, Inc. | Sustained release peptide formulations |
| WO2019219714A1 (en) | 2018-05-15 | 2019-11-21 | Novo Nordisk A/S | Compounds capable of binding to melanocortin 4 receptor |
| WO2020053414A1 (en) | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Bicyclic compounds capable of acting as melanocortin 4 receptor agonists |
| KR102087634B1 (ko) * | 2018-10-11 | 2020-03-11 | (주)바이텍 | 항비만용 조성물 |
| SG11202106847SA (en) * | 2019-01-04 | 2021-07-29 | Kineta Chronic Pain Llc | Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions |
| IL294521A (en) | 2020-02-18 | 2022-09-01 | Novo Nordisk As | glp-1 compounds and their uses |
| CN111718408A (zh) * | 2020-07-06 | 2020-09-29 | 成都圣诺生物制药有限公司 | 一种Setmelanotide的制备方法 |
| JP2024532294A (ja) * | 2021-08-24 | 2024-09-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Ｍｃ４ｒアゴニストペプチド |
| WO2023080712A1 (ko) * | 2021-11-05 | 2023-05-11 | ㈜아이엠디팜 | 신규한 서방성 지질 전구 제제 및 이를 포함하는 서방성 주사용 약학 조성물 |
| WO2023247999A1 (en) * | 2022-06-24 | 2023-12-28 | Mainline Biosciences (Shanghai) Co., Ltd. | Peptidic pain modulators and methods for producing and using the same |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849704A (en) * | 1991-12-20 | 1998-12-15 | Novo Nordisk A/S | Pharmaceutical formulation |
| AU6785094A (en) | 1993-05-07 | 1994-12-12 | Sequus Pharmaceuticals, Inc. | Subcutaneous liposome delivery method |
| US5795587A (en) * | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US5731408A (en) * | 1995-04-10 | 1998-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Peptides having potent antagonist and agonist bioactivities at melanocortin receptors |
| US5968895A (en) | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| US20070185032A1 (en) * | 1996-12-11 | 2007-08-09 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| CA2433335C (en) * | 2000-12-29 | 2010-04-20 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
| AU2002322466B2 (en) * | 2001-07-11 | 2007-08-30 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptides |
| US20040097419A1 (en) * | 2002-11-19 | 2004-05-20 | Holger Petersen | Organic compounds |
| FR2851563B1 (fr) | 2003-02-26 | 2005-04-22 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| FR2852957B1 (fr) | 2003-03-31 | 2005-06-10 | Sod Conseils Rech Applic | Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament |
| EA200600055A1 (ru) * | 2003-06-19 | 2006-08-25 | Эли Лилли Энд Компани | Агонисты рецептора меланокортина 4 (мк4 ) и их применение |
| FR2862971B1 (fr) | 2003-11-28 | 2006-03-24 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| KR100638041B1 (ko) | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
| FR2872165B1 (fr) | 2004-06-24 | 2006-09-22 | Sod Conseils Rech Applic | Nouveaux derives de pyrimido-benzimidazole |
| ES2663916T3 (es) | 2005-07-08 | 2018-04-17 | Ipsen Pharma | Ligandos de los receptores de la melanocortina |
| EP1915168A4 (en) | 2005-07-08 | 2010-03-31 | Ipsen Pharma | LIGANDS OF MELANOCORTIN RECEPTORS |
| CA2689016C (en) | 2007-05-25 | 2014-08-12 | Ipsen Pharma S.A.S. | Melanocortin receptor ligands modified with hydantoin |
| EP2167112A4 (en) | 2007-06-15 | 2012-01-25 | Ipsen Pharma Sas | CYCLIC PEPTIDE MELANOCORTIN RECEPTOR LIGANDS |
| EP2979703B1 (en) | 2007-11-05 | 2018-07-18 | Ipsen Pharma S.A.S. | Use of melanocortins to treat insulin sensitivity |
| AR072072A1 (es) * | 2008-06-09 | 2010-08-04 | Palatin Technologies Inc | Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669 |
| EP2317975B1 (en) * | 2008-06-25 | 2016-04-13 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
| CN101439182B (zh) * | 2008-12-18 | 2012-02-01 | 北京大学 | 一种生长抑素受体介导的肿瘤靶向药物组合物 |
| BRPI1009644B1 (pt) * | 2009-06-08 | 2022-02-08 | Palatin Technologies, Inc | Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica |
| UY32690A (es) * | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| MX2012001513A (es) | 2009-08-05 | 2012-05-22 | Ipsen Pharma Sas | Uso de melanocortinas para tratar la dislipidemia. |
| WO2011060355A1 (en) | 2009-11-16 | 2011-05-19 | Ipsen Pharma S.A.S | Process for the synthesis of ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2 |
| JP5486690B2 (ja) | 2009-11-16 | 2014-05-07 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | メラノコルチン受容体リガンドの医薬組成物 |
| KR102038677B1 (ko) | 2011-06-14 | 2019-10-30 | 입센 파마 에스.에이.에스 | 활성 성분으로 멜라노코르틴 수용체 리간드를 함유하는 지속-방출형 조성물 |
| JP2013046596A (ja) | 2011-08-29 | 2013-03-07 | Alpha-Nano-Medica Co Ltd | 新規な複合体、それを含有する医薬及び癌の治療方法 |
| WO2013033838A1 (en) | 2011-09-09 | 2013-03-14 | Pharmagap Inc. | Liposomal formulations of cationic peptides and uses thereof |
| EP2705835A1 (en) | 2012-06-08 | 2014-03-12 | Ipsen Pharma S.A.S. | Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release |
| JP6622690B2 (ja) * | 2013-03-15 | 2019-12-18 | リズム・ファーマシューティカルズ・インコーポレイテッド | ペプチド組成物 |
| JP6538025B2 (ja) | 2013-03-15 | 2019-07-03 | リズム・ファーマシューティカルズ・インコーポレイテッド | 医薬組成物 |
-
2014
- 2014-03-14 JP JP2016503089A patent/JP6538025B2/ja active Active
- 2014-03-14 CN CN201480026783.9A patent/CN105518021A/zh active Pending
- 2014-03-14 WO PCT/US2014/029421 patent/WO2014144842A2/en not_active Ceased
- 2014-03-14 PL PL14724574T patent/PL2970389T3/pl unknown
- 2014-03-14 CA CA3209602A patent/CA3209602A1/en active Pending
- 2014-03-14 RU RU2015143965A patent/RU2690377C2/ru active
- 2014-03-14 EP EP20185463.5A patent/EP3778623A1/en active Pending
- 2014-03-14 PT PT147245740T patent/PT2970389T/pt unknown
- 2014-03-14 CN CN202211043853.4A patent/CN115957296A/zh active Pending
- 2014-03-14 CA CA2906782A patent/CA2906782C/en active Active
- 2014-03-14 AU AU2014228460A patent/AU2014228460B2/en active Active
- 2014-03-14 US US14/775,911 patent/US11129869B2/en active Active
- 2014-03-14 KR KR1020157029620A patent/KR102378943B1/ko active Active
- 2014-03-14 DK DK14724574.0T patent/DK2970389T3/da active
- 2014-03-14 IL IL288961A patent/IL288961B1/en unknown
- 2014-03-14 BR BR112015023409-7A patent/BR112015023409B1/pt active IP Right Grant
- 2014-03-14 EP EP14724574.0A patent/EP2970389B1/en active Active
- 2014-03-14 CN CN202211043877.XA patent/CN115957297A/zh active Pending
- 2014-03-14 ES ES14724574T patent/ES2825076T3/es active Active
-
2015
- 2015-09-09 IL IL241378A patent/IL241378B/en unknown
-
2019
- 2019-01-08 AU AU2019200101A patent/AU2019200101B2/en active Active
- 2019-06-05 JP JP2019104944A patent/JP2019189619A/ja active Pending
-
2021
- 2021-04-30 AU AU2021202699A patent/AU2021202699A1/en not_active Abandoned
- 2021-08-13 US US17/401,929 patent/US12285460B2/en active Active
- 2021-12-03 NO NO2021051C patent/NO2021051I1/no unknown
- 2021-12-06 NL NL301149C patent/NL301149I2/nl unknown
- 2021-12-14 FR FR21C1059C patent/FR21C1059I2/fr active Active
-
2022
- 2022-02-17 JP JP2022023265A patent/JP2022065117A/ja active Pending
-
2023
- 2023-07-12 AU AU2023204625A patent/AU2023204625A1/en not_active Abandoned
-
2024
- 2024-09-27 JP JP2024169338A patent/JP2025004067A/ja active Pending
-
2025
- 2025-03-31 US US19/096,163 patent/US20260053885A1/en active Pending
- 2025-08-05 AU AU2025213562A patent/AU2025213562A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021000792B8 (enExample) | ||
| AT524874A5 (enExample) | ||
| AT524834A2 (enExample) | ||
| AU2018438767B1 (enExample) | ||
| AT521543A3 (enExample) | ||
| AT524961A5 (enExample) | ||
| AT524266A2 (enExample) | ||
| BR102019026286B1 (pt) | Método e aparelho para o avanço de produtos a serem moldados | |
| BR102019025884B1 (pt) | Sistema de segurança aprimorado para máquinas de operação de autopropulsão | |
| BR112021008727B1 (pt) | Método para monitorar e controlar o tratamento de um fluxo de água residual municipal ou um fluxo de água residual industrial e aparelho para tratamento de monitoramento e controle de um fluxo de água residual municipal ou industrial | |
| BR102019023514B1 (pt) | Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna | |
| BR112021001434B1 (pt) | Aço com alto teor de manganês e método de produção do mesmo | |
| BR112021001374B1 (pt) | Composição farmacêutica para o tratamento da hipertensão e seu uso | |
| BR112021001128B1 (pt) | Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit | |
| BR112021001186B1 (pt) | Aparelho para o tratamento de celulite para tratar expressões de celulite na pele de um paciente associadas a um local de tratamento de septos | |
| BR112021000922B1 (pt) | Tela de filtro, e, método para purificar água de alimentação | |
| BR112020023832B1 (pt) | Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral | |
| BR112020024987B1 (pt) | Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico | |
| BR112020023823B1 (pt) | Distribuidor | |
| BR112020022482B1 (pt) | Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico | |
| BR112020022658B1 (pt) | Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido | |
| BR112020022516B1 (pt) | Processo para degomagem enzimática de óleo | |
| BR112020021042B1 (pt) | Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas | |
| BR112020020812B1 (pt) | Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado | |
| BR112020015757B1 (pt) | Métodos, sistema, kit e dispositivos para visualização e remoção de tumor |